Enterobacter sakazakii (Cronobacter spp.) in powdered follow-up formula: meeting report

Overview

This report aims at highlighting the currently available data on the prevalence of E. sakazakii (Cronobacter spp.) in products categorized as follow-up formula for infants and how it contributes to our knowledge base and facilitates risk management decisions. In addition, the limitations of that data, particularly in relation to the narrow spectrum of the global population which it represents, are provided. In this context the analysis should provide guidance to risk managers a s to whether there is any value in establishing a microbiological criterion for FUF.